Aspirin use for the prevention of cardiovascular disease: The British Women's Heart and Health Study

British Journal of General Practice

Volumn 51, Issue 470, 2001, Pages 743-745

  Lawlor, D A ^a   Bedford, C ^a   Taylor, M ^a   Ebrahim, S ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Aspirin; Cardiovascular disease; Post menopause; Women

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEASIBILITY STUDY; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; POSTMENOPAUSE; PREVENTION AND CONTROL; PRIMARY HEALTH CARE; UNITED KINGDOM;

AGED; ASPIRIN; CARDIOVASCULAR DISEASES; CONFIDENCE INTERVALS; FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTMENOPAUSE;

EID: 0034845872     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Collaborative overview of randomised trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration
2. Aspirin use in middle-aged men with cardiovascular disease: Are opportunities being missed?
3. Sex differences in risk factors, treatment and mortality after acute myocardial infarction: An observational study
4. British Regional Heart Study: Cardiovascular risk factors in middle-aged men in 24 towns
5. Risk of gastrointestinal haemorrhage with long term use of aspirin: Meta-analysis
6. Who benefits from medical interventions?